Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : email@example.com
|Drug Name||Trade Name||Synonyms||Drug Classes||Drug Description|
|Meclizine||Ancolan||Meclizine is a antagonist of the histidine receptor (H1) that also interferes with cellular respiration, potentially resulting in decreased cell viability (PMID: 20160716).|
|Molecular Profile||Indication/Tumor Type||Response Type||Therapy Name||Approval Status||Evidence Type||Efficacy Evidence||References|
|Clinical Trial||Phase||Therapies||Title||Recruitment Status||Covered Countries||Other Countries|
|NCT03253289||Phase I||Meclizine||Meclizine for Hepatocellular Carcinoma (OPTIM)||Active, not recruiting||USA||0|